Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 15 member 2 (SLC15A2), commonly known as PEPT2, is a high-affinity, low-capacity proton-coupled transporter primarily responsible for the reabsorption of di- and tripeptides in the kidney. It is localized to the apical membrane of the renal proximal tubule and is also significantly expressed in the choroid plexus, lung, and mammary glands (UniProt, 1.4.3; Wikipedia, 1.4.5). In the brain, SLC15A2 plays a critical role in maintaining neuropeptide homeostasis by facilitating the efflux of peptide fragments from the cerebrospinal fluid (PubMed, 1.3.1). Beyond endogenous peptides, the transporter is a key determinant in the pharmacokinetics of various peptidomimetic drugs, including beta-lactam antibiotics, ACE inhibitors, and antiviral prodrugs (Guide to Pharmacology, 1.2.1). Genetic polymorphisms in SLC15A2, such as the PEPT2*2 variant, have been associated with altered susceptibility to environmental toxins like lead and may influence drug response (PubMed, 1.4.4). Its involvement in the transport of bacterial peptidoglycans also links it to innate immune responses via the NOD2 signaling pathway (MapMyGenome, 1.3.2). Consequently, SLC15A2 is a significant target for optimizing drug delivery and understanding inter-individual variability in drug disposition and toxicity.
Substrate for proton-coupled electrogenic symport, facilitating the uphill transport of di- and tripeptides across the plasma membrane driven by a proton gradient.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 15 member 2 (PEPT2) (SLC15A2).